213 related articles for article (PubMed ID: 24849656)
1. Neutrophil-Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis.
Gökmen F; Akbal A; Reşorlu H; Gökmen E; Güven M; Aras AB; Erbağ G; Kömürcü E; Akbal E; Coşar M
J Clin Lab Anal; 2015 Jul; 29(4):294-8. PubMed ID: 24849656
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study.
Al-Osami MH; Awadh NI; Khalid KB; Awadh AI
Adv Rheumatol; 2020 Jan; 60(1):13. PubMed ID: 32000859
[TBL] [Abstract][Full Text] [Related]
3. Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.
Bozan N; Alpaycı M; Aslan M; Cankaya H; Kıroglu AF; Turan M; Ayral A; Senkoy E; Ilter S
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3663-3672. PubMed ID: 27034281
[TBL] [Abstract][Full Text] [Related]
4. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Saad CG; Ribeiro AC; Moraes JC; Takayama L; Goncalves CR; Rodrigues MB; de Oliveira RM; Silva CA; Bonfa E; Pereira RM
Arthritis Res Ther; 2012 Oct; 14(5):R216. PubMed ID: 23062122
[TBL] [Abstract][Full Text] [Related]
5. The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis.
Mercan R; Bitik B; Tufan A; Bozbulut UB; Atas N; Ozturk MA; Haznedaroglu S; Goker B
J Clin Lab Anal; 2016 Sep; 30(5):597-601. PubMed ID: 26666737
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.
Coşkun BN; Öksüz MF; Ermurat S; Tufan AN; Oruçoğlu N; Doğan A; Dalkılıç E; Pehlivan Y
Eur J Rheumatol; 2014 Sep; 1(3):101-105. PubMed ID: 27708888
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-lymphocyte and platelet-lymphocyte rate and their seasonal differences in ankylosing spondylitis and rheumatoid arthritis patients using anti-TNF medication.
Enginar AU; Kacar C
Bratisl Lek Listy; 2019; 120(8):586-592. PubMed ID: 31379182
[TBL] [Abstract][Full Text] [Related]
8. Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis.
Inci U; Yildiz A; Batmaz I; Tekbas E
Int J Rheum Dis; 2017 Feb; 20(2):238-244. PubMed ID: 26012572
[TBL] [Abstract][Full Text] [Related]
9. Is increased neutrophil lymphocyte ratio remarking the inflammation in sarcopenia?
Öztürk ZA; Kul S; Türkbeyler İH; Sayıner ZA; Abiyev A
Exp Gerontol; 2018 Sep; 110():223-229. PubMed ID: 29928932
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Platelets-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Rheumatoid Arthritis and Ankylosing Spondylitis.
Khan S; Yousaf MJ; Rashid A; Manzar A
J Coll Physicians Surg Pak; 2024 Jan; 34(1):68-72. PubMed ID: 38185964
[TBL] [Abstract][Full Text] [Related]
11. Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation.
Güneş M; Büyükgöl H
Int J Neurosci; 2020 Nov; 130(11):1095-1100. PubMed ID: 31983256
[No Abstract] [Full Text] [Related]
12. Effect of ozone therapy on neutrophil/lymphocyte, platelet/lymphocyte ratios, and disease activity in ankylosing spondylitis: a self-controlled randomized study.
Inci H; İnci F
Med Gas Res; 2023; 13(2):53-58. PubMed ID: 36204783
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the relationship between blood cell markers and inflammation, disease activity, and general health status in ankylosing spondylitis.
Sariyildiz A; Benlidayi IC; Turk I; Acemoglu SSZ; Unal I
Rev Assoc Med Bras (1992); 2023; 69(10):e20230722. PubMed ID: 37729230
[TBL] [Abstract][Full Text] [Related]
14. The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis.
Karkucak M; Capkin E; Alver A; Akyuz A; Kiris A; Ak E; Topbas M; Tosun M
Clin Rheumatol; 2010 Mar; 29(3):303-7. PubMed ID: 20012550
[TBL] [Abstract][Full Text] [Related]
15. Radiologic parameters of ankylosing spondylitis patients treated with anti-TNF-α versus nonsteroidal anti-inflammatory drugs and sulfasalazine.
Son SM; Choi SH; Shin JK; Goh TS; Lee JS
Eur Spine J; 2019 Apr; 28(4):649-657. PubMed ID: 30742244
[TBL] [Abstract][Full Text] [Related]
16. Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.
Korkosz M; Gąsowski J; Leszczyński P; Pawlak-Buś K; Jeka S; Siedlar M; Grodzicki T
Scand J Rheumatol; 2014; 43(1):43-8. PubMed ID: 24447112
[TBL] [Abstract][Full Text] [Related]
17. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
Park JW; Kim MJ; Lee JS; Ha YJ; Park JK; Kang EH; Lee YJ; Song YW; Lee EY
Arthritis Rheumatol; 2019 Jan; 71(1):82-90. PubMed ID: 29984487
[TBL] [Abstract][Full Text] [Related]
18. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.
Pan L; Du J; Li T; Liao H
BMJ Open; 2017 May; 7(4):e014451. PubMed ID: 28473512
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil lymphocyte ratio in patients with ankylosing spondylitis: A systematic review and meta-analysis.
Xu S; Ma Y; Wu M; Zhang X; Yang J; Deng J; Guan S; Gao X; Xu S; Shuai Z; Guan S; Chen L; Pan F
Mod Rheumatol; 2020 Jan; 30(1):141-148. PubMed ID: 30605008
[No Abstract] [Full Text] [Related]
20. Investigation of effects of two-different treatment modalities on nerve conduction in patients with ankylosing spondylitis.
Capkin E; Karkucak M; Kose MM; Çakmak VA; Turkyilmaz AK; Tosun M
Rheumatol Int; 2012 Feb; 32(2):431-4. PubMed ID: 21120488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
